Pfizer's rare disease drug gets EMA's positive recommendation
Pfizer Inc said on Friday the European Medicines Agency granted the company a positive recommendation for approval of its treatment for a rare disorder that occurs in patients with cardiomyopathy.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: Cardiology | Cardiomyopathy | European Medicines Agency (EMA) | Health | Heart | Pfizer | Rare Diseases